Bevacizumab: a safe and effective treatment in a patient with advanced colorectal cancer and repeated removal of metastases.
Bevacizumab has been shown to be effective combined with chemotherapy for first-line treatment of advanced colorectal cancer, but little information is available about its efficacy and safety in patients who may be candidates for surgery at any time during the disease. The case history of a female patient with colorectal cancer, undergoing surgery for liver metastases and bilateral surgery for lung metastases at different time-points during her disease, is reported. Perioperative bevacizumab administration caused no complications either associated with surgery, in the early postoperative period, or in the subsequent months.
Castro-Carpeño
Javier de
Jd
Department of Medical Oncology, La Paz University Hospital, Madrid Autonomous University, Madrid, Spain.
Moyano
María Sereno
MS
Sáenz
Enrique Casado
EC
Belda-Iniesta
Cristóbal
C
Batlle
Jaime Feliu
JF
Barón
Manuel González
MG